Form 4: Kenvue Officer Granted 98,994 Restricted Stock Units
Insider Transaction Report
Kenvue Inc.'s Group President APAC, Anindya Dasgupta, was granted 98,994 Restricted Stock Units, vesting over three years.
Summary
- Anindya Dasgupta, Group President APAC of Kenvue Inc., received a grant of 98,994 Restricted Stock Units (RSUs).
- The transaction date for this grant was March 2, 2026.
- These RSUs correspond one-for-one with Kenvue's common stock.
- The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029.
- Vesting is contingent upon Dasgupta's continued service to the company through each vesting date.
- Following this transaction, Dasgupta beneficially owns 98,994 derivative securities (RSUs) directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value and executive retention.
Positives
- The grant of 98,994 Restricted Stock Units aligns the executive's interests with long-term shareholder value.
- The three-year vesting schedule encourages executive retention and sustained performance within the company.
Risks
- Vesting of the Restricted Stock Units is subject to the reporting person's continued service, meaning unvested units could be forfeited if employment ceases before the vesting dates.
Future Outlook
The grant of Restricted Stock Units with a multi-year vesting schedule indicates Kenvue's strategy to incentivize long-term executive retention and align management's interests with the company's sustained performance and shareholder value creation.
Management Comments
- No direct management quotes are provided in this Form 4 filing, which is typical for this document type.
Industry Context
StockSavvy.ai notes that the grant of Restricted Stock Units is a common practice in the consumer health industry and broader corporate landscape for executive compensation, aiming to align management incentives with long-term company performance and shareholder returns. This type of equity award is standard for retaining key talent like a Group President for a significant regional market such as APAC.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice across the consumer goods and healthcare sectors, comparable to companies like Procter & Gamble (PG), Johnson & Johnson (JNJ), and Unilever (UL), which frequently utilize equity awards to incentivize long-term performance.
- A three-year vesting schedule, with equal annual installments, is a common structure for RSU grants, providing a balance between immediate incentive and long-term retention, consistent with industry benchmarks for executive equity awards.
- The grant size of 98,994 RSUs for a Group President of a major region like APAC is within the expected range for an executive at this level in a company of Kenvue's size and market capitalization, reflecting competitive compensation practices.
Stakeholder Impact
- Shareholders: The grant aligns executive interests with long-term shareholder value, potentially fostering sustained growth.
- Employees: Reflects standard executive compensation practices, which can influence overall compensation philosophy and retention strategies.
Next Steps
- The RSUs will vest in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of RSU grant to Anindya Dasgupta. |
| 03/04/2026 | Date the Form 4 was signed by the attorney-in-fact. |
| 03/02/2027 | First vesting installment date for the Restricted Stock Units. |
| 03/02/2028 | Second vesting installment date for the Restricted Stock Units. |
| 03/02/2029 | Third and final vesting installment date for the Restricted Stock Units. |
Recommendation
holdThis Form 4 filing reports a routine executive compensation event (RSU grant) and does not contain information that would fundamentally alter the investment thesis for Kenvue. It reinforces management's long-term alignment but does not provide new operational or financial data to warrant a change in investment recommendation.
Keywords
Kenvue, KVUE, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Anindya Dasgupta, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.